DNABIOSCI “Innovation in aptamer-based therapeutics” Biotechnological and biomedical research in the European Union is advancing through innovative laboratory studies that explore the therapeutic and diagnostic potential of aptamers and lead molecules. Aptamers, short single-stranded DNA or RNA sequences selected by Systematic Evolution of Ligands by Exponential Enrichment (SELEX), exhibit strong specificity and binding affinity to